Ads
related to: Mylan Pharmaceuticals, Inc
Search results
25 Biggest Pharmaceutical Companies in the World A Year Ago
Insider Monkey via Yahoo Finance· 2 years agoIn this article we listed the 25 biggest pharmaceutical companies in the world a year ago and then...
U.S. Supreme Court turns away Biogen bid to reinstate MS drug patent
Reuters via Yahoo News· 2 years agoWASHINGTON (Reuters) -The U.S. Supreme Court on Monday declined to hear Biogen Inc's bid to win...
The Viatris Inc (VTRS) Company: A Short SWOT Analysis
GuruFocus.com via Yahoo Finance· 5 months agoStrengths: Viatris Inc's expansive global presence and diversified portfolio position it as a leader...
Viatris (VTRS) to Report Q2 Earnings: What's in the Cards?
Zacks via Yahoo Finance· 2 years agoViatris VTRS, a global healthcare company, is scheduled to report second-quarter 2022 results on Aug...
Unveiling Viatris (VTRS)'s Value: Is It Really Priced Right? A Comprehensive Guide
GuruFocus.com via Yahoo Finance· 7 months agoViatris Inc (NASDAQ:VTRS), a pharmaceutical giant formed through the merger of Upjohn and Mylan,...
Unraveling Viatris Inc's Potential Underperformance: A Deep Dive into the GF Score
GuruFocus.com via Yahoo Finance· 8 months agoLong-established in the Drug Manufacturers industry, Viatris Inc (NASDAQ:VTRS) has enjoyed a stellar...
Chris Davis Reduces Stake in Viatris Inc
GuruFocus.com via Yahoo Finance· 2 months agoChris Davis (Trades, Portfolio), through Davis Advisors, has recently adjusted the firm's holdings in the pharmaceutical company Viatris Inc...
Insider Sell Alert: President, Greater China Xiangyang Ni Sells 14,937 Shares of Viatris Inc (VTRS)
GuruFocus.com via Yahoo Finance· 5 months agoIn the realm of stock market movements, insider trading activity is often a significant indicator...
US Supreme Court spurns Sanofi appeal to revive EpiPen suit against Viatris
Reuters via Yahoo Finance· 1 year agoWASHINGTON (Reuters) -The U.S. Supreme Court on Monday declined to hear a bid by Sanofi SA to revive...
Merck wins ruling upholding diabetes-treatment patent at U.S. appeals court
Reuters via Yahoo Finance· 2 years agoA Merck Sharp & Dohme Corp patent related to its diabetes drugs Januvia and Janumet is valid, a U.S. appeals court said Thursday, rejecting a challenge to the patent by generic drugmaker Mylan ...
